FATE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: FATE Shares Outstanding History and FATE YTD Return |
FATE Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: FATE Shares Outstanding History and FATE YTD Return |
FATE Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+6.57% CAGR Mouse over chart for data details
|
FATE Stock Price Chart |
About Fate Therapeutics Inc |
Fate Therapeutics is a clinical-stage biopharmaceutical company focused on the development of programmed cellular immunotherapies for patients with cancer. Co. is developing cell therapy product candidate. Co.'s off-the-shelf, induced pluripotent stem cells (iPSC) derived cellular immunotherapy pipeline include: FT516, which is an off-the-shelf natural killer (NK) cell cancer immunotherapy derived from a clonal master iPSC line engineered to express a high-affinity, non-cleavable CD16 Fc receptor; and FT596, which is an off-the-shelf chimeric antigen receptor NK cell cancer immunotherapy derived from a clonal engineered master iPSC line. We show 41 historical shares outstanding datapoints in our FATE shares outstanding history coverage, used to compute FATE market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing FATE market cap history over the course of time is important for investors interested in comparing FATE's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of FATE versus a peer is one thing; comparing FATE market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like FATE can fluctuate over the course of history. With this page we aim to empower investors researching FATE by allowing them to research the FATE market cap history. |
FATE Current Stock Quote |
Free FATE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
FATE Share Performance |
Market Cap Peers |
Fate Therapeutics (FATE) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
FBIO Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.